Hudson Bay Capital Management LP - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,357,500
+129.3%
1,050,000
+165.8%
0.02%
+21.4%
Q2 2023$1,899,950
-29.4%
395,000
-40.4%
0.01%
+16.7%
Q1 2023$2,690,432
+107.6%
662,668
+176.1%
0.01%
-7.7%
Q4 2022$1,296,000240,0000.01%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders